For price and detailed agenda, visit the site and request the agenda!
The latest outcomes of the effects of COVID19 on the delay of new product launch
Can Price Transparency contribute to more affordable patient access to medicines?
Reaching a better integration of regulatory pathways
A look into the personalized reimbursement system
Early Payer Engagement
Equal access and multi-indication medicines